{"url_path":"/sec/pbh/10-k/2026/item-11","section_key":"item-11","section_title":"Item 11 EXECUTIVE COMPENSATION","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1295947/0001295947-26-000016-index.html","accession_number":"0001295947-26-000016","cik":"0001295947","ticker":"PBH","issuer_name":"Prestige Consumer Healthcare Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1295947/0001295947-26-000016-index.html","primary_entity_key":"0001295947","primary_entity_name":"Prestige Consumer Healthcare Inc."},"word_count":60,"has_tables":true,"body_markdown":"ITEM 11. EXECUTIVE COMPENSATION\n\n                    \n\nInformation required to be disclosed by this Item will be contained in the Company’s 2026 Proxy Statement under the headings “Executive Compensation and Other Matters”, “Governance of the Company”, \"Compensation Discussion and Analysis\", \"Compensation and Talent Management Committee Report\" and \"Compensation and Talent Management Committee Interlocks and Insider Participation\", which information is incorporated herein by reference."}